YD Bio Limited (YDES)
NASDAQ: YDES · Real-Time Price · USD
13.91
+1.13 (8.89%)
At close: Dec 5, 2025, 4:00 PM EST
14.18
+0.28 (1.98%)
After-hours: Dec 5, 2025, 7:47 PM EST
YD Bio Market Cap
YD Bio has a market cap or net worth of $977.80 million as of December 5, 2025. Its market cap has increased by 1,835.60% in one year.
Market Cap
977.80M
Enterprise Value
974.69M
1-Year Change
1,835.60%
Ranking
Category
Stock Price
$13.91
Market Cap Chart
Since December 23, 2020, YD Bio's market cap has increased from $148.36M to $977.80M, an increase of 559.09%. That is a compound annual growth rate of 46.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 977.80M | 2,054.72% |
| Dec 26, 2024 | 45.38M | -4.31% |
| Dec 28, 2023 | 47.42M | -5.87% |
| Dec 30, 2022 | 50.38M | -66.30% |
| Dec 31, 2021 | 149.47M | 3.24% |
| Dec 31, 2020 | 144.79M | -2.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |